王庆国教授运用柴胡达原饮治疗一例特殊疑似COVID-19分析  

Professor Wang Qingguo Treatment of a Special Suspected COVID-19 with Bupleurum Membrane-Source-Opening Decoction

作　　者：申建国[1] 王健[1] 陈志兴 王庆国[2] Shen Jianguo;Wang Jian;Chen Zhixing;Wang Qingguo(Cangzhou Hospital of Integrated TCM-WM,Cangzhou 061000,China;Beijing University of Chinese Medicine,Beijing 100029,China)

机构地区：[1]沧州中西医结合医院,河北沧州061000 [2]北京中医药大学,北京100029

出　　处：《亚太传统医药》2023年第10期129-133,共5页Asia-Pacific Traditional Medicine

摘　　要：柴胡达原饮出自清代俞根初所著《重订通俗伤寒论》,是在吴又可《瘟疫论》达原饮方加减化裁而来,治疗湿热阻遏膜原之证。COVID-19患者多表现为湿热阻遏膜原,患者西药常规治疗11天,病情逐步加重,王庆国教授予柴胡达原饮加减治疗,症状得到迅速改善。通过病案来分析探讨COVID-19湿热阻遏膜原证的治疗。Bupleurum Membrane-Source-Opening Decoction comes from the book re ordering the theory of common typhoid fever written by Yu genchu in the Qing Dynasty,It came from Wu Youke's treatise on pestilence to add and subtract the Membrane-Source-Opening Decoction,Treatment of dampness and heat repressing the interpleuro-diaphragmatic space.COVID-19 patients are mostly manifested as dampness and heat repressing the interpleuro-diaphragmatic space,the patient was treated with western medicine for 11 days,the disease is getting worse.Professor Wang Qingguo gives Bupleurum Membrane-Source-Opening Decoction plus or minus treatment.The symptoms improved rapidly.This case is to analyze and discuss the treatment of damp heat repression membrane of novel coronavirus pneumonia.

关 键 词：COVID-19 柴胡达原饮 湿热阻遏膜原 个案报告 

分 类 号：R249[医药卫生—中医临床基础] R278[医药卫生—中医学]